vs

Side-by-side financial comparison of MakeMyTrip Ltd (MMYT) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

MakeMyTrip Ltd is the larger business by last-quarter revenue ($88.6M vs $87.2M, roughly 1.0× Schrodinger, Inc.). On growth, MakeMyTrip Ltd posted the faster year-over-year revenue change (11.8% vs -1.2%).

MakeMyTrip Limited is an Indian online travel company, headquartered in Gurgaon. Founded in 2000, it operates an online travel-booking platform for travel services such as airline tickets, hotel reservations, holiday packages, and rail and bus tickets. The company also maintains offices outside India, including locations in New York, Singapore, Kuala Lumpur, Phuket, Bangkok, Dubai and Istanbul.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

MMYT vs SDGR — Head-to-Head

Bigger by revenue
MMYT
MMYT
1.0× larger
MMYT
$88.6M
$87.2M
SDGR
Growing faster (revenue YoY)
MMYT
MMYT
+13.0% gap
MMYT
11.8%
-1.2%
SDGR

Income Statement — Q4 FY2022 vs Q4 FY2025

Metric
MMYT
MMYT
SDGR
SDGR
Revenue
$88.6M
$87.2M
Net Profit
$32.5M
Gross Margin
65.7%
Operating Margin
3.8%
-19.7%
Net Margin
37.3%
Revenue YoY
11.8%
-1.2%
Net Profit YoY
180.8%
EPS (diluted)
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MMYT
MMYT
SDGR
SDGR
Q4 25
$87.2M
Q3 25
$54.3M
Q2 25
$54.8M
Q1 25
$59.6M
Q4 24
$88.3M
Q3 24
$35.3M
Q2 24
$47.3M
Q1 24
$36.6M
Net Profit
MMYT
MMYT
SDGR
SDGR
Q4 25
$32.5M
Q3 25
$-32.8M
Q2 25
$-43.2M
Q1 25
$-59.8M
Q4 24
$-40.2M
Q3 24
$-38.1M
Q2 24
$-54.0M
Q1 24
$-54.7M
Gross Margin
MMYT
MMYT
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
MMYT
MMYT
SDGR
SDGR
Q4 25
-19.7%
Q3 25
-84.6%
Q2 25
-96.6%
Q1 25
-85.5%
Q4 24
-23.5%
Q3 24
-193.9%
Q2 24
-111.4%
Q1 24
-184.3%
Net Margin
MMYT
MMYT
SDGR
SDGR
Q4 25
37.3%
Q3 25
-60.4%
Q2 25
-78.8%
Q1 25
-100.4%
Q4 24
-45.5%
Q3 24
-108.1%
Q2 24
-114.2%
Q1 24
-149.5%
EPS (diluted)
MMYT
MMYT
SDGR
SDGR
Q4 25
$0.45
Q3 25
$-0.45
Q2 25
$-0.59
Q1 25
$-0.82
Q4 24
$-0.55
Q3 24
$-0.52
Q2 24
$-0.74
Q1 24
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MMYT
MMYT
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$213.3M
$395.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$896.5M
$364.1M
Total Assets
$1.3B
$726.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MMYT
MMYT
SDGR
SDGR
Q4 25
$395.5M
Q3 25
$391.2M
Q2 25
$450.2M
Q1 25
$500.3M
Q4 24
$352.1M
Q3 24
$388.7M
Q2 24
$377.3M
Q1 24
$431.1M
Stockholders' Equity
MMYT
MMYT
SDGR
SDGR
Q4 25
$364.1M
Q3 25
$321.4M
Q2 25
$342.9M
Q1 25
$373.5M
Q4 24
$421.4M
Q3 24
$449.4M
Q2 24
$474.0M
Q1 24
$513.7M
Total Assets
MMYT
MMYT
SDGR
SDGR
Q4 25
$726.2M
Q3 25
$653.7M
Q2 25
$688.2M
Q1 25
$743.0M
Q4 24
$823.2M
Q3 24
$669.3M
Q2 24
$688.4M
Q1 24
$737.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MMYT
MMYT
SDGR
SDGR
Operating Cash FlowLast quarter
$-16.1M
Free Cash FlowOCF − Capex
$-16.1M
FCF MarginFCF / Revenue
-18.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MMYT
MMYT
SDGR
SDGR
Q4 25
$-16.1M
Q3 25
$-61.9M
Q2 25
$-52.2M
Q1 25
$144.1M
Q4 24
$-31.1M
Q3 24
$-33.3M
Q2 24
$-53.7M
Q1 24
$-39.3M
Free Cash Flow
MMYT
MMYT
SDGR
SDGR
Q4 25
$-16.1M
Q3 25
$-62.4M
Q2 25
$-52.5M
Q1 25
$143.5M
Q4 24
$-32.0M
Q3 24
$-34.6M
Q2 24
$-54.7M
Q1 24
$-43.4M
FCF Margin
MMYT
MMYT
SDGR
SDGR
Q4 25
-18.5%
Q3 25
-114.8%
Q2 25
-95.9%
Q1 25
240.9%
Q4 24
-36.2%
Q3 24
-98.0%
Q2 24
-115.6%
Q1 24
-118.5%
Capex Intensity
MMYT
MMYT
SDGR
SDGR
Q4 25
0.0%
Q3 25
0.9%
Q2 25
0.6%
Q1 25
1.0%
Q4 24
1.0%
Q3 24
3.8%
Q2 24
2.1%
Q1 24
11.2%
Cash Conversion
MMYT
MMYT
SDGR
SDGR
Q4 25
-0.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MMYT
MMYT

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons